Adam Kadlec
Directeur Général chez Rivermark Medical, Inc.
Postes actifs de Adam Kadlec
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Golden Angels Investors LLC
 Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Consultant / Advisor | 01/04/2018 | - |
Rivermark Medical, Inc.
 Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec. | Directeur/Membre du Conseil | - | - |
| Directeur Général | 01/08/2021 | - | |
| President | 01/08/2021 | - |
Historique de carrière de Adam Kadlec
Formation de Adam Kadlec
| University of Wisconsin | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Consultant / Advisor | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Finance | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Golden Angels Investors LLC
Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Finance |
Rivermark Medical, Inc.
Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec. | Health Technology |
- Bourse
- Insiders
- Adam Kadlec
- Expérience
